Literature DB >> 8668682

Acyloxymethyl as a drug protecting group. Part 3. Tertiary O-amidomethyl esters of penicillin G: chemical hydrolysis and anti-bacterial activity.

R Moreira1, T Calheiros, J Cabrita, E Mendes, M Pimentel, J Iley.   

Abstract

PURPOSE: O-(N-alkylamido)methyl esters of penicillin G were studied as a new class of prodrugs.
METHODS: The hydrolysis in aqueous buffers containing 20 % (v/v) of acetonitrile was investigated by HPLC.
RESULTS: A U-shaped pH-rate profile was seen with a pH-independent process extending from pH ca. 2 to pH ca. 10. This pathway is characterised by kinetic data that are consistent with a unimolecular mechanism involving rate-limiting iminium ion formation and penicillinoate expulsion. Penicillin G and the corresponding amide are the ultimate products detected and isolated, indicating that beta-lactam ring opening is much slower than ester hydrolysis. The O-(N-alkylamido)methyl esters of penicillin G displayed similar in vitro antibacterial activity to penicillin G itself.
CONCLUSIONS: Compared to the penicillin G derivatives, the much higher stability of the O-(N-methylbenzamido)methyl benzoate, acetate and valproate esters (which gave rise to a Bronsted Beta 1g value of ca. -1) suggests that tertiary N-acyloxymethylamides may be useful prodrugs for carboxylic acid drugs with pKa > 4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668682     DOI: 10.1023/a:1016077200460

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

1.  Prodrugs as drug delivery systems. 74. Facile hydrolysis of N-(acyloxymethyl)amide derivatives and implications for the design of prodrugs of NH-acidic compounds and of carboxylic acids.

Authors:  H Bundgaard; N M Nielsen
Journal:  Acta Pharm Suec       Date:  1987

2.  Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time.

Authors:  N A Nguyen; L M Mortada; R E Notari
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

3.  Orally active esters of cephalosporin antibiotics. 3. Synthesis and biological properties of aminoacyloxymethyl esters of 7-[D(-)-mandelamido]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-3-cephem-4-carboxylic acid.

Authors:  W J Wheeler; D A Preston; W E Wright; G W Huffman; H E Osborne; D P Howard
Journal:  J Med Chem       Date:  1979-06       Impact factor: 7.446

4.  Prodrugs of peptides. 11. Chemical and enzymatic hydrolysis kinetics of N-acyloxymethyl derivatives of a peptide-like bond.

Authors:  H Bundgaard; G J Rasmussen
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

5.  Phenytoin prodrugs III: water-soluble prodrugs for oral and/or parenteral use.

Authors:  S A Varia; S Schuller; K B Sloan; V J Stella
Journal:  J Pharm Sci       Date:  1984-08       Impact factor: 3.534

  5 in total
  3 in total

1.  Acyloxymethyl as a drug protecting group: Part 4. The hydrolysis of tertiary amidomethyl ester prodrugs of carboxylic acid agents.

Authors:  J Iley; R Moreira; T Calheiros; E Mendes
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

2.  A Methyl 4-Oxo-4-phenylbut-2-enoate with in Vivo Activity against MRSA that Inhibits MenB in the Bacterial Menaquinone Biosynthesis Pathway.

Authors:  Joe S Matarlo; Yang Lu; Fereidoon Daryaee; Taraneh Daryaee; Bela Ruzsicska; Stephen G Walker; Peter J Tonge
Journal:  ACS Infect Dis       Date:  2016-03-07       Impact factor: 5.084

3.  Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug.

Authors:  Morten Rohde; Niels M Rk; Anders E Håkansson; Klaus G Jensen; Henrik Pedersen; Tina Dige; Erling B J Rgensen; René Holm
Journal:  Results Pharma Sci       Date:  2014-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.